Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03070886
Title Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors NRG Oncology
Indications

prostate adenocarcinoma

Therapies

Bicalutamide + Docetaxel + Flutamide + Goserelin + Leuprolide + Nilutamide

Bicalutamide + Flutamide + Goserelin + Leuprolide + Nilutamide

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.